Aimei Health Technology Co., Ltd

AFJKNASDAQFinancial Services● Active

$36.28

$-4.12(-10.20%)

Market Cap$222096473

P/E Ratio—

52W High$130.37

52W Low$6.75

Avg Volume18K

Open$40.31

Beta0.23

Revenue Financials Earnings

Aimei Health Technology Co., Ltd (AFJK) Revenue

Annual & quarterly revenue history · segment & region breakdown

AFJK · revenue · updated Jun 8, 2026

Core revenue metrics

Trailing 12 months

Aimei Health Technology Co., Ltd trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY2025 $0.00B

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

2 employees

FY2025

$0.00B

FY2024

$0.00B

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Aimei Health Technology Co., Ltd SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

2025 – 2023 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2025-12-31	$0.00B	+$0.00B	—
2024-12-31	$0.00B	+$0.00B	—
2023-12-31	$0.00B	—	—

AFJK revenue by year · AFJK revenue history · AFJK annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Aimei Health Technology Co., Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Aimei Health Technology Co., Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Aimei Health Technology Co., Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

AFJK revenue · 4 questions

AFJK's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.

AFJK revenueAFJK annual revenuewhat is AFJK revenueAFJK TTM revenue

▸ Source: FMP · Aimei Health Technology Co., Ltd SEC filings · GAAP · Aimei Health Technology Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026